Companies: 48,874 Total Market Cap: 132429386156445.04

Teva Pharmaceutical Industries Limited

NYSE: TEVA
Healthcare Drug Manufacturers - Specialty & Generic
Rank #1061
Market Cap 19.38 B
Volume 2.90 M
Price 16.90
Change (%) 0.24%
Country or region Israel Israel

Teva Pharmaceutical Industries Limited's latest marketcap:

19.38 B

As of 05/19/2025, Teva Pharmaceutical Industries Limited's market capitalization has reached $19.38 B. According to our data, Teva Pharmaceutical Industries Limited is the 1061th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 19.38 B
Revenue (ttm) 16.62 B
Net Income (ttm) -1,286,000,000
Shares Out 1.15 B
EPS (ttm) -1.14
Forward PE 6.66
Ex-Dividend Date n/a
Earnings Date 05/07/2025
Market Cap Chart
Data Updated: 05/19/2025

Teva Pharmaceutical Industries Limited's yearly market capitalization.

Teva Pharmaceutical Industries Limited has seen its market value grow from $5.70 B to $19.38 B since 1998, representing a total increase of 240.09% and an annual compound growth rate (CAGR) of 4.75%.
Date Market Cap Change (%)
05/19/2025 $19.38 B -19.16%
12/31/2024 $24.97 B 113.39%
12/29/2023 $11.70 B 15.54%
12/30/2022 $10.13 B 14.65%
12/31/2021 $8.84 B -16.46%
12/31/2020 $10.58 B -1.18%
12/31/2019 $10.70 B -31.87%
12/31/2018 $15.71 B -18.33%
12/29/2017 $19.23 B -41.54%
12/30/2016 $32.90 B -41.16%
12/31/2015 $55.92 B 2.69%
12/31/2014 $54.45 B 43.98%
12/31/2013 $37.82 B 7.52%
12/31/2012 $35.17 B -7.04%
12/30/2011 $37.84 B -21.4%
12/31/2010 $48.14 B -3.59%
12/31/2009 $49.93 B 45.08%
12/31/2008 $34.41 B -6.66%
12/31/2007 $36.87 B 83.46%
12/29/2006 $20.10 B -25.46%
12/30/2005 $26.96 B 62.59%
12/31/2004 $16.58 B 13.05%
12/31/2003 $14.67 B 46.88%
12/31/2002 $9.99 B -41.7%
12/28/2001 $17.13 B -16.54%
12/29/2000 $20.52 B 104.36%
12/31/1999 $10.04 B 76.19%
12/31/1998 $5.70 B

Company Profile

About Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries Limited is a global leader in the development, manufacturing, and distribution of generic medicines, biopharmaceutical products, and active pharmaceutical ingredients. Headquartered in Tel Aviv, Israel, the company operates across the United States, Europe, and international markets.

Key Offerings

  • Generic Medicines: Available in tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams.
  • Specialty Products: Sterile formulations, hormones, high-potency drugs, and cytotoxic substances.
  • Therapeutic Focus: Central nervous system (CNS), respiratory, and oncology treatments.
  • Contract Manufacturing: Provides API production and out-licensing services for pharmaceutical companies.

Notable Products

  • BENDEKA & TREANDA: For chronic lymphocytic leukemia and non-Hodgkin’s lymphoma.
  • COPAXONE: Treats relapsing forms of multiple sclerosis.
  • AJOVY: Preventive migraine treatment for adults.
  • AUSTEDO: Addresses Huntington’s disease and tardive dyskinesia.
  • UZEDY: Schizophrenia treatment.
  • Respiratory Solutions: ProAir RespiClick, QVAR RediHaler, BRALTUS, and AirDuo RespiClick.

Over-the-Counter (OTC) Brands

  • SUDOCREM
  • NasenDuo
  • DICLOX FORTE
  • OLFEN Max
  • FLEGAMINA

Strategic Collaborations

Teva partners with industry leaders including MedinCell S.A., Sanofi, Alvotech, Biolojic Design Ltd., and MODAG GmbH to enhance innovation and expand its product portfolio.

Founded: 1901 | Headquarters: Tel Aviv, Israel

Frequently Asked Questions

As of 05/19/2025, Teva Pharmaceutical Industries Limited (including the parent company, if applicable) has an estimated market capitalization of $19.38 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Teva Pharmaceutical Industries Limited global market capitalization ranking is approximately 1061 as of 05/19/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Israel
Founded 1901
IPO Date n/a
Employees 36,830
CEO Richard Francis
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Address 124 Dvora HaNevi’a St.
Tel Aviv, 6944020
Israel
Website https://www.tevapharm.com
People Also Watch
Zoetis
163.66 0.24%
Merck KGaA
129.19 0.24%
Haleon plc
541.86 0.24%
NSE-SUNPHARMA
20.24 0.24%